|
Subsequent Events (Details Textual) (USD $)
|
1 Months Ended |
6 Months Ended |
|
Jul. 31, 2012
|
Jan. 31, 2012
|
Jun. 30, 2012
|
| Subsequent Events (Additional Textual) [Abstract] |
|
|
|
| Borrowings from Robert Gipson |
$ 150,000 |
|
|
| Interest rate stated in the contractual debt agreement |
|
|
7.00% |
| Non-refundable sum in exchange for exclusive option to license |
|
500,000 |
|
| Sublicense execution payment |
|
(175,000) |
|
| Contingent milestone payments, maximum |
|
2,900,000 |
|
| Contingent milestone payments occur at the time of product registration or upon commercial sales |
|
2,500,000 |
|
| Maximum effective declaration period |
|
90 days |
|
| Convertible Note Purchase Agreement to receive repayment of a total |
16,000,000 |
|
|
| Convertible Note Purchase Agreement at a rate |
8.00% |
|
|
| Prospective Repayment Of Debt Pursuant To Waiver Of Right To Receive Percentage of Altropane Product Sale |
|
|
$ 5,827,587 |
|
Navb Stock [Member]
|
|
|
|
| Subsequent Events (Textual) [Abstract] |
|
|
|
| Shares Received Against Execution Of Sublicense Granted |
|
300,000 |
|
|
Navidea stock [Member]
|
|
|
|
| Subsequent Events (Textual) [Abstract] |
|
|
|
| Issuance common shares of Navidea stock maximum |
|
1,150,000 |
|
| Issuance common shares of Navidea stock occur at the time of product registration or upon commercial sales |
|
950,000 |
|